VOCASEPT PLUS LOZENGES

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

dichlorobenzyl alcohol, Quantity: 1.2 mg; lidocaine hydrochloride monohydrate, Quantity: 10 mg; amylmetacresol, Quantity: 0.6 mg

Disponibbli minn:

Mapaex Consumer Healthcare (Australia) Pty Ltd

Għamla farmaċewtika:

Lozenge

Kompożizzjoni:

Excipient Ingredients: glucose; tartaric acid; saccharin sodium; Mentha X piperita; quinoline yellow; purified water; menthol; sucrose; Flavour

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

8,12,16,24,32,36

Tip ta 'preskrizzjoni:

Not scheduled. Not considered by committee

Indikazzjonijiet terapewtiċi:

For the symptomatic relief of minor mouth and throat infections, including sore throat and the relief of symptoms of inflammation.

Sommarju tal-prodott:

Visual Identification: A yellow coloured, round, flat bevelled lozenges.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2022-02-07